Advanced Wireless, Wearable Sensors for Continuous Hemodynamic Monitoring

N/ACompletedNCT04362553

Northwestern University42 enrolled

Overview

Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring

Study Type

OBSERVATIONAL

Enrollment

Conditions

Congestive Heart Failure

Interventions

wearable vital signs sensorDEVICE

vital signs monitoring during standard of care procedures; TTE, swan-ganz catheterization

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria 1. Patient's aged 18-65 2. Patient's scheduled to undergo a Trans-thoracic Echocardiogram (TTE) in an outpatient cardiology clinic or admitted to the Cardiac Care Unit with a swan ganz catheter in place for continuous invasive hemodynamic monitoring Exclusion Criteria 1. Patient's with fragile skin or skin conditions that would prevent them from having a sensor placed 2. Patients undergoing exercise or drug induced cardiac stress test 3. Patients with a visible wound at site of sensor placement 3.4. Patients with structural or functional limitations to peripheral blood flow (known upper extremity peripheral arterial disease, use of vasopressors etc.).

Locations (1)

Northwestern Memorial Hospital

Chicago, Illinois, United States

Outcomes

Primary Outcomes

Percent agreement with pilot sensor and current standard of vital signs monitoring

Time frame: 2 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.